[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Sunday, 30 July 2006, 23:02 GMT 00:02 UK
Muscular dystrophy reversal clue
Image of skeletal muscle
MD affects the muscles of the body
US scientists have found a way to reverse muscular dystrophy (MD) in mice, offering hope of a cure for humans with muscle-wasting diseases.

The animals in the Nature Genetics study had myotonic dystrophy - the most common form of MD in adults.

The therapy targets a particular kind of toxic molecule to "silence" its presence in the diseased muscle.

The University of Virginia team showed the treatment fully restored heart and skeletal muscle function in mice.

In myotonic dystrophy, like the other types of MD, faulty DNA is to blame for the abnormalities that occur.

Weakness

Myotonic dystrophy occurs because of a large expansion of DNA code, which most likely causes an accumulation of toxic messenger RNA molecules in cells.

Messenger or mRNA is a copy of the information carried by a gene on the DNA. If the DNA code is faulty then the mRNA will be faulty too.

These abnormalities lead to the progressive muscle weakness and wasting and heart problems seen in myotonic dystrophy.

The results of the research are encouraging for finding a treatment for myotonic dystrophy
Dr Marita Pohlschmidt
Muscular Dystrophy Campaign
Dr Mani Mahadevan and his team reasoned that eliminating the toxic mRNA molecules might help reverse the disease.

They created mice with faulty DNA that could be turned on and off by adding or removing an antibiotic to their drinking water.

In the "on" phase the mice showed all the cardinal features of myotonic dystrophy. When the DNA was turned off, normal skeletal and cardiac muscle function was restored in many, but not all of the mice.

Proof of principle

Although the treatment was not 100% effective, the researchers believe their results provide the proof scientists have been waiting for to demonstrate that it might be possible to reverse muscular dystrophy.

They said: "The results represent the first in vivo proof of principle for a therapeutic strategy for treatment of myotonic dystrophy by ablating or silencing expression of the toxic RNA molecules."

Their work also suggests that it is indeed the toxic mRNA that causes the pathology.

They said: "The fact that the course of the disease can be reversed both overtly and at the molecular level suggests that the toxic RNA functions as a reversible metabolic toxin."

Dr Marita Pohlschmidt, of the Muscular Dystrophy Campaign, UK, said: "The results of the research are encouraging for finding a treatment for myotonic dystrophy.

"It might be possible to reverse the symptoms of myotonic dystrophy when the toxic substance causing the condition is neutralised.

"However, there is still a lot that needs to be done before we can be sure that this will be successful."




SEE ALSO

RELATED BBC LINKS

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific